BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Solomon JM, Paul F, Chien C, Oh J, Rotstein DL. A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course. Ther Adv Neurol Disord 2021;14:17562864211014389. [PMID: 34035837 DOI: 10.1177/17562864211014389] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Cacciaguerra L, Pagani E, Radaelli M, Mesaros S, Martinelli V, Ivanovic J, Drulovic J, Filippi M, Rocca MA. MR T2-relaxation time as an indirect measure of brain water content and disease activity in NMOSD. J Neurol Neurosurg Psychiatry 2022:jnnp-2022-328956. [PMID: 35483915 DOI: 10.1136/jnnp-2022-328956] [Reference Citation Analysis]
2 Bartels F, Lu A, Oertel FC, Finke C, Paul F, Chien C. Clinical and neuroimaging findings in MOGAD-MRI and OCT. Clin Exp Immunol 2021. [PMID: 34152000 DOI: 10.1111/cei.13641] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Deng S, Lei Q, Lu W. Pregnancy-Related Attack in Neuromyelitis Optica Spectrum Disorder With AQP4-IgG: A Single-Center Study and Meta-Analysis. Front Immunol 2021;12:800666. [PMID: 35069584 DOI: 10.3389/fimmu.2021.800666] [Reference Citation Analysis]
4 Costello F, Burton JM. Contemporary management challenges in seropositive NMOSD. J Neurol 2022. [PMID: 35816205 DOI: 10.1007/s00415-022-11241-5] [Reference Citation Analysis]
5 Ouellette R. Advanced MRI quantification of neuroinflammatory disorders. J Neurosci Res 2022;100:1389-94. [PMID: 35460291 DOI: 10.1002/jnr.25054] [Reference Citation Analysis]
6 Xie JS, Jeeva-Patel T, Margolin E. Baló's concentric sclerosis - A rare entity within the spectrum of demyelinating diseases. J Neurol Sci 2021;428:117570. [PMID: 34261000 DOI: 10.1016/j.jns.2021.117570] [Reference Citation Analysis]